| Overview | Amylases 30000 Unt / Endopeptidases 19000 Unt / Lipase 6000 Unt Delayed Release Oral Capsule (also know as Creon) is a capsule shaped, blue and orange, delayed release pellets capsule that is approximately 14 mm in size. It has one score and can be broken into two pieces. It is imprinted with "CREON" and "1206" and is supplied by Abbvie Inc. |
|---|---|
| Drug Name | Creon |
| Dosage Form | Delayed Release Pellets Capsule |
| Imprint(s) | CREON, 1206 |
| Pill Size | 14 mm |
| Color | |
| Shape | |
| Score | |
| DEA Schedule (Potential for Drug Abuse) |
| Active Ingredient(s) | Pancrelipase Amylase, Pancrelipase Lipase, Pancrelipase Protease |
|---|---|
| Inactive Ingredient(s) | Cetyl Alcohol, Dimethicone, Triethyl Citrate, FD&C Blue No. 2, Ferric Oxide Red, Hypromellose Phthalate, Sodium Lauryl Sulfate, Titanium Dioxide, Ferric Oxide Yellow, Polyethylene Glycol, Unspecified, Gelatin, Unspecified |
| RxNorm Concept Unique Identifier | 863,836 |
|---|---|
| National Drug Code | 321206 |
| Marketing Category | NDA |
| Supplier | Abbvie Inc. |
|---|---|
| References | The data for Amylases 30000 Unt / Endopeptidases 19000 Unt / Lipase 6000 Unt Delayed Release Oral Capsule (also know as Creon) was updated by the U.S National Library of Medicine on April 19, 2018.
|
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.